Abstract:Background: NOD like receptor pyrin domain containing 3 (NLRP3) inflammasome is involved in innate immunity, and related to liver injury. However, no inflammasome inhibitors are clinically available until now. Our previous research suggests that isolicoflavonol (ILF), isolated from Macaranga indica, is a potent NLRP3 inflammasome inhibitor, but its mechanism is unclear. Methods: Fluorescent imaging and Western blot assay were used to ascertain the effects of ILF on pyroptosis and NLRP3 inflammasome activation in macrophages. Next, Nrf2 signal pathway, its downstream gene transcription and expression were further investigated. ML385, a Nrf2 inhibitor, was used to verify whether ILF targets Nrf2 signaling. A carbon tetrachloride induced liver injury model was introduced to evaluate the liver protection activity of ILF in mice. Results: This work revealed that ILF inhibited macrophage LDH release and IL-1β secretion in a dose-dependent manner. ILF had no significant cytotoxic effect on macrophage, it reduced pyroptosis and Gasdermin D N-terminal fragment formation. Moreover, ILF inhibited IL-1β maturation and Caspase-1 cleavage, but did not affect NLRP3, pro-Caspase-1, pro-IL-1β and ASC expression. ILF decreased ASC speck rate and reduced ASC oligomer formation. ILF decreased aggregated JC-1 formation restoring mitochondria membrane potential. In addition, ILF increased Nrf2 expression, extended Nrf2 lifespan and upregulated Nrf2 signaling pathway in macrophages whether the NLRP3 inflammasome was activated or not. Besides, ILF increased Nrf2 nuclear translocation, maintained a high proportion of Nrf2 in the nucleus, and upregulated ARE-related gene transcription and expression. Furthermore, Nrf2 signal inhibition attenuated compound ILF-mediated inhibition of pyroptosis, inflammasome activation and upregulation of Nrf2 signaling. ILF in a liver injury mouse model inhibited NLRP3 inflammasome activation and enhanced Nrf2 signaling. Conclusion: Our study verified that ILF ameliorates liver injury via inhibiting NLRP3 inflammasome activation through boosting Nrf2 signaling, and highlighted that ILF is a potent anti-inflammatory drug for inflammasome-related liver diseases.

FR167653 Attenuates Murine Immunological Liver Injury

Amelioration of Dextran Sulfate Sodium-Induced Experimental Ulcer Colitis in Mice by Bacillus licheniformis

The effect of histone deacetylase inhibitor ACY1215 on the inflammatory response in mice with acute liver failure

Effect of baicalin on immune hepatic injury induced by BCG plus LPS in mice

A New Suppressive Agent Against Interleukin-1Β and Tumor Necrosis Factor-Α Enhances Liver Regeneration after Partial Hepatectomy in Rats

Effect of Leflunomide on Immunological Liver Injury in Mice

FR-167653 attenuates acute hepatic failure after partial hepatectomy in cirrhotic rats

<i>Bifidobacterium longum</i> R0175 Protects Rats against D-Galactosamine-Induced Acute Liver Failure

Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in d -galactosamine-treated rats

Bacillus amyloliquefaciens SC06 Attenuated Lipopolysaccharide-Induced acute liver injury by suppressing bile acid-associated NLRP3 inflammasome activation

Effects and mechanisms of FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor, on adjuvant arthritis in rats.

Protective Effect of Recombinant Human IL-1Ra on CCl4-induced Acute Liver Injury in Mice.

Potential Mechanism of Protective Effect of Liver X Receptor Activation on A-Galcer-induced Liver Injury in Mice

Glucocorticoids Alleviates Lipopolysaccharide-Induced Acute Liver Injury Associated With Promoting The Expression Of Ntcp And Bsep

Augmenter of Liver Regeneration Ameliorates Ischemia-Reperfusion Injury in Steatotic Liver Via Inhibition of the TLR4/NF-κB Pathway.

Isolicoflavonol ameliorates acute liver injury via inhibiting NLRP3 inflammasome activation through boosting Nrf2 signaling in vitro and in vivo

Protective effect of acteoside on immunological liver injury induced by Bacillus Calmette-Guerin plus lipopolysaccharide.

Alleviation of LPS-induced Acute Inflammation by Glabridin Administration and Its Mechanisms in Mice

Pretreatment with Interleukin-33 Reduces Warm Hepatic Ischemia/reperfusion Injury in Mice.

Protective Effects of Bml-111, A Lipoxin A(4) Receptor Agonist, on Carbon Tetrachloride-Induced Liver Injury in Mice

[Paeoniflorin ameliorates liver injury of MRL/lpr mice through inhibition of NF-κB pathway]